|
|
|
|
Excelsior Medical receives Canadian marketing license for new, pre-filled catheter lock syringe
Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it has received a Medical Device License from Health Canada for its new, pre-filled catheter lock syringe to be sold in the Canadian...
|
|
|
PolyMedix provides overview of its 2010 clinical milestones
In the first quarter of 2010, PolyMedix anticipates initiating a Phase 1B/2 pilot proof-of-concept study in the United States to evaluate the safety and efficacy of a single-dose of PMX-60056 on healthy subjects who have received a low molecular weight ...
|
|
|
PolyMedix Announces Planned Milestones for 2010
RADNOR, Pa.(BUSINESS WIRE) PolyMedix, Inc.(OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, provided an overview of its 2010...
|
|
|
FDA: drug safety benefits of import inspection system easy to Predict
The US FDA says its new screening system will expedite the importation of genuine drugs and help inspectors focus their efforts on high risk products.At present, customs officials only examine a fraction of the 20m shipments that reach US ports each year,...
|
|
|
FDA: drug safety benefits of import inspection system easy to Predict
The US FDA says its new screening system will expedite the importation of genuine drugs and help inspectors focus their efforts on high risk products.At present, customs officials only examine a fraction of the 20m shipments that reach US ports each year,...
|
|
|
FDA: drug safety benefits of import inspection system easy to Predict
The US FDA says its new screening system will expedite the importation of genuine drugs and help inspectors focus their efforts on high risk products.At present, customs officials only examine a fraction of the 20m shipments that reach US ports each year,...
|
|
|
FDA: drug safety benefits of import inspection system easy to Predict
The US FDA says its new screening system will expedite the importation of genuine drugs and help inspectors focus their efforts on high risk products.At present, customs officials only examine a fraction of the 20m shipments that reach US ports each year,...
|
|
|
Excelsior Medicals New Catheter Lock Solution Approved by Health Canada
NEPTUNE, N.J.--(BUSINESS WIRE)--Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it has received a Medical Device License from Health Canada for its new, pre-filled catheter lock syringe...
|
|
|
Preliminary study results of ExThera Medical's Seraph extracorporeal affinity therapy published
ExThera Medical announced today that the results of a preliminary study (Cytokines in blood from septic patients interact with surface immobilized heparin) of its proprietary medical device, Seraph extracorporeal affinity therapy, have been published in...
|
|
|
PolyMedix Announces Planned Milestones for 2010
On-Track to Initiate 4 Clinical Trials RADNOR, Pa.--(BUSINESS WIRE)--Feb 9, 2010 - PolyMedix, Inc.(OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute...
|
|
|
PolyMedix Announces Planned Milestones for 2010
Companies mentioned in this article: PolyMedix, Inc.RADNOR, Pa. -- (BUSINESS WIRE) -- PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute...
|
|
|
PolyMedix Announces Planned Milestones for 2010
PolyMedix, Inc.(OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, provided an overview of its 2010 clinical milestones in a...
|
|
|
Export amount of Heparin in Nov. 2009
_ Export amount of Heparin in Nov.2009.
|
|
|
Report on Swedish life science cluster
Stockholm-Uppsala Life Science has published a comprehensive report on the research expertise in the Stockholm-Uppsala region of Sweden.The region currently hosts over 500 life science companies, 300 major research projects and more than 25,000 employees...
|
|
|
FDA: drug safety benefits of import inspection system easy to Predict
Related topics: Globalisation, Industry Drivers, Ingredients, excipients and raw materials The US FDA says its new screening system will expedite the importation of genuine drugs and help inspectors focus their efforts on high risk products.At present,...
|
|
|
Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the
BERKELEY, Calif.--(EON: Enhanced Online News)--ExThera Medical announced today that the results of a preliminary study (Cytokines in blood from septic patients interact with surface immobilized heparin) of its proprietary medical device, Seraph...
|
|
|
Bridging anticoagulation discrepancies detected among US hospitals
MedWire News: Anticoagulation management in patients undergoing surgery varies among hospitals and does not depend solely on patient characteristics, suggest study findings published in the American Journal of Medicine.The researchers examined the rates of...
|
|
|
Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 causes of death in the U.S.
GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); BERKELEY, Calif.- (Business Wire) ExThera Medical announced today that the results of a preliminary study (Cytokines in blood from septic patients interact with surface immobilized heparin)...
|
|
|
Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the
Study results published in current issue of ASAIO Journal BERKELEY, Calif.--(BUSINESS WIRE)--ExThera Medical announced today that the results of a preliminary study (Cytokines in blood from septic patients interact with surface immobilized heparin) of its...
|
|
|
Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 causes of death in the U.S.
Study results published in current issue of ASAIO Journal BERKELEY, Calif.--(BUSINESS WIRE)-- ExThera Medical announced today that the results of a preliminary study ("Cytokines in blood from septic patients interact with surface immobilized heparin") of...
|
|
|
Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 causes of death in the U.S.
Study results published in current issue of ASAIO Journal BERKELEY, Calif.--(BUSINESS WIRE)--ExThera Medical announced today that the results of a preliminary study (Cytokines in blood from septic patients interact with surface immobilized heparin) of its...
|
|
|
Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 causes of death in the U.S.
Companies mentioned in this article: ExThera Medical BERKELEY, Calif.-- (BUSINESS WIRE) -- ExThera Medical announced today that the results of a preliminary study (Cytokines in blood from septic patients interact with surface immobilized heparin) of...
|
|
|
Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 causes of death in the U.S.
Companies mentioned in this article: ExThera Medical BERKELEY, Calif.-- (BUSINESS WIRE) -- ExThera Medical announced today that the results of a preliminary study (Cytokines in blood from septic patients interact with surface immobilized heparin) of...
|
|
|
Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 causes of death in the U.S.
ExThera Medical announced today that the results of a preliminary study ("Cytokines in blood from septic patients interact with surface immobilized heparin") of its proprietary medical device, Seraph extracorporeal affinity therapy, have been published in...
|
|
|
Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 cau
BERKELEY, Calif.- (BUSINESS WIRE) - ExThera Medical announced today that the results of a preliminary study ("Cytokines in blood from septic patients interact with surface immobilized heparin" ) of its proprietary medical device, Seraph extracorporeal...
|
